U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 15-21, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: November 15-21, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 11/17/2020
Location: Virtual
Subject: A Conversation with FDA Commissioner Dr. Stephen M. Hahn: The FDA Emergency Use Authorization (EUA) Process for COVID-19 Vaccines and Testing
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Regulatory Affairs Professional Society

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 11/19/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, patient groups, industry, and other stakeholders

Event Date: 11/19/2020
Location: Virtual
Subject: CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, patient groups, industry, and other stakeholders

Event Date: 11/19/2020
Location: Virtual
Subject: CBD Work Group Listening Session with Supplement Safety Solutions / CV Sciences
FDA Participant/Group: COLIN ROM; ROBIN APPLEBERRY; DOMINIC CHIAPPERINO; CASSANDRA TAYLOR; SHERENE SEPEHRI; EMILY ROSE CAREY; TRISTAN COLONIUS; CHARLOTTE CONWAY; APRIL ALEXANDROW; NATHAN ARNOLD; SHARON MAYL; NICHOLAS ALEXANDER; ALISON THOMPSON; JOSEPH FRANKLIN; MATTHEW SCHERER; CARA WELCH; DOUGLAS THROCKMORTON; RACHEL OSTERMAN;
Non FDA Participant/Group: Stephen Schmitz (Supplement Safety Solutions); Douglas MacKay (CV Sciences, Inc.);

Event Date: 11/20/2020
Location: Virtual
Subject: Roundtable on Next Generation IT in Health Care
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/17/2020
Location: Virtual
Subject: Food Safety Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Members from across food industry, academia, state and federal government

Event Date: 11/18/2020
Location: Virtual
Subject: Proposed Rule for Requirements for Additional Traceability Records for Certain Foods
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Consumers, food industry, academia, state and federal government

Event Date: 11/19/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from the Arizona farming industry and Arizona Department of Agriculture

Event Date: 11/19/2020
Location: Virtual
Subject: Panel on New Era of Smarter Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the National GS1 Traceability Advisory Group and Food Standards from Australia and New Zealand

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/16/2020
Location: Virtual
Subject: Operation Warp Speed Convalescent Plasma Collection Question and Answer Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Florida Hospital Association education event

Event Date: 11/16/2020
Location: Virtual
Subject: American Society of Gene and Cell Therapy / FDA Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the American Society of Gene and Cell Therapy

Event Date: 11/18/2020
Location: Virtual
Subject: Plasma Protein Therapeutics Association / FDA Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the Plasma Protein Therapeutics Association

Event Date: 11/18/2020
Location: Virtual
Subject: How the COVID-19 Pandemic is Impacting the Rare Disease Community
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants in the Orphan Drugs and Rare Diseases Global Congress

Event Date: 11/18/2020
Location: Virtual
Subject: American Society of Hematology Clinical News Interview: Opportunities for Hematologists at FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the American Society of Hematology

Event Date: 11/18/2020
Location: Virtual
Subject: Health, Hospitals & Social Services Committee Meeting: Question and Answer Session on COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the Bronx Community Board No. 8 - Health, Hospitals & Social Services Committee

Event Date: 11/19/2020
Location: Virtual
Subject: FDA’s Regulatory Approach to Applications of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants in the CRISPR 2.0: Next Generation Genome Editing Congress

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 11/18/2020
Location: Virtual
Subject: Medical Device Innovation Consortium: Patient Engagement Forum
FDA Participant/Group: JODI DUCKHORN; MICHELLE TARVER; ALICIA WITTERS;
Non FDA Participant/Group: Communication experts, patients, and medical device industry leaders

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event

 

Back to Top